Fuan Pharmaceutical Group Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is TIGECYCLINE, with a corresponding US DMF Number 27477.
Remarkably, this DMF maintains an Active status since its submission on August 19, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 15, 2014, and payment made on September 30, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II